This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Adds a new federal "abortion pill reversal informed consent" provision to the Public Health Service Act, preserves any state laws that require greater disclosure or penalties related to abortion, and contains a severability clause so the rest of the law remains if a part is struck down. The bill provides no text for the new informed-consent requirement and includes no funding, enforcement details, or agency instructions in the supplied material.
The bill preserves state authority to require stronger abortion disclosures (which may increase information for some patients) but risks restricting patient decision‑making and imposing administrative, legal, and financial burdens on providers that could reduce access to care.
State governments can preserve or enact stronger abortion disclosure rules, maintaining state regulatory authority over counseling and disclosure policy.
People in states that choose stronger protections may receive more information and stricter enforcement around abortion disclosures, which could increase patient awareness and oversight in those states.
Women and pregnant people may be subject to mandated counseling or disclosures that limit medical decision‑making, include medically disputed claims (for example about abortion‑pill 'reversal'), and create additional barriers to timely care.
Healthcare providers and clinics could face increased administrative and compliance burdens, higher legal and financial risks, and uncertainty from added disclosure requirements — raising costs and potentially deterring providers, which would reduce access to services.
Patients and providers may be exposed to greater legal and liability risk if required disclosures rely on non‑evidence‑based information or lack clear clinical standards, increasing the chance of lawsuits and inconsistent medical practice.
Introduced September 18, 2025 by August Pfluger · Last progress September 18, 2025